Global Fund

Global Fund - The Genesis Engine

• Established: 2002, Geneva, Switzerland.
• Genesis: Prompted by G8 Summit (Okinawa, 2000) & UNGA Special Session on HIV/AIDS (2001).
• Mission: To attract, leverage and invest additional resources to end the epidemics of HIV/AIDS, Tuberculosis, and Malaria (ATM) to support attainment of the Sustainable Development Goals.
• Vision: A world free of the burden of AIDS, Tuberculosis and Malaria.
• Key Objectives:
  • Raise & invest funds.
  • Support locally-driven programs.
  • Performance-based funding.
  • Partnership & inclusivity.

⭐ High-Yield Fact: The Global Fund operates as a financing mechanism, not an implementing agency. It relies on local expertise to implement programs.

Global Fund - The Big Three Battle

The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) is a pivotal financing partnership targeting these three major infectious diseases.

• HIV/AIDS Strategy:

  • Expanding access to Antiretroviral Therapy (ART).
  • Prevention: Condoms, Pre-Exposure Prophylaxis (PrEP), voluntary medical male circumcision (VMMC).
  • Supporting testing, counseling, and care.

• Tuberculosis (TB) Control:

  • Implementing the DOTS (Directly Observed Treatment, Short-course) strategy.
  • Enhancing diagnostics (e.g., Xpert MTB/RIF).
  • Addressing drug-resistant TB (DR-TB).

• Malaria Elimination Efforts:

  • Mass distribution of Long-Lasting Insecticidal Nets (LLINs).
  • Providing Artemisinin-based Combination Therapies (ACTs).
  • Supporting Indoor Residual Spraying (IRS).

• Cross-Cutting Investment:

  • Resilient and Sustainable Systems for Health (RSSH): Strengthening health infrastructure, supply chains, and human resources.

⭐ The Global Fund is a financing mechanism, not an implementing agency; it relies on local expertise to carry out programs in countries. It has saved an estimated 59 million lives as of mid-2023 through its partnerships and investments in fighting the three diseases and strengthening health systems.

Global Fund - Cash & Command Chain

• Funding Model:
  • Mechanism: Donor pledges from governments, private sector, and foundations.
  • Replenishment Cycles: Funds raised via replenishment conferences, typically every 3 years for sustained support.
• Governance & Command Chain:
  • Board: Apex decision-making body. Members: donors, recipients, civil society, private sector, affected communities.
  • Secretariat: Geneva-based. Manages daily operations, grant management, resource mobilization.
  • Technical Review Panel (TRP): Independent experts; review grant proposals for technical soundness, strategic focus.
  • Country Coordinating Mechanisms (CCMs): National multi-stakeholder platforms. Develop/submit funding requests; oversee country-level program implementation.

⭐ The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) is a financing mechanism, not an implementing agency.

Global Fund & India - Bharat's Health Boost

• India's Dual Role: Major recipient of Global Fund grants, and increasingly a donor, reflecting its commitment to global health.
• Key Programs Supported:
  • HIV/AIDS: Bolsters National AIDS Control Organisation (NACO) for prevention, testing, and treatment.
  • Tuberculosis: Critical support to National TB Elimination Program (NTEP), aiming for TB elimination by 2025.
  • Malaria: Aids National Vector Borne Disease Control Programme (NVBDCP) in malaria elimination efforts.
• Achievements: Significant ↓ in incidence & mortality for HIV, TB, and malaria; improved access to diagnostics & treatment.

⭐ India is the first G20 country and BRICS nation to transition from being solely a recipient to also becoming a donor to the Global Fund.

High‑Yield Points - ⚡ Biggest Takeaways

• The Global Fund primarily targets AIDS, Tuberculosis, and Malaria (ATM).
• Established in 2002; headquartered in Geneva, Switzerland.
• Acts as a financing partnership, not an implementing body.
• Mobilizes and invests significant resources (e.g., nearly US$4 billion annually).
• India is a key donor and recipient country.
• Utilizes performance-based funding for grants.
• Aims to end these epidemics by 2030, aligning with SDGs (Sustainable Development Goals).